celastrol has been researched along with Chronic Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moudgil, KD; Venkatesha, SH | 1 |
| Dumont, S; Hentsch, D; Kessler, P; Moreira-Tabaka, H; Muller, CD; Peluso, J; Reimund, JM; Vonesch, JL | 1 |
2 other study(ies) available for celastrol and Chronic Illness
| Article | Year |
|---|---|
Celastrol and Its Role in Controlling Chronic Diseases.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Autoimmune Diseases; Chronic Disease; Humans; Inflammation; Pentacyclic Triterpenes; Signal Transduction; Triterpenes | 2016 |
Unlike for human monocytes after LPS activation, release of TNF-α by THP-1 cells is produced by a TACE catalytically different from constitutive TACE.
Topics: ADAM Proteins; ADAM17 Protein; Animals; Benzoquinones; Cell Line; Cell Membrane; Chronic Disease; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Hydroxamic Acids; Inflammation; Inhibitory Concentration 50; Lipopolysaccharides; Mice; Microscopy, Confocal; Monocytes; Pentacyclic Triterpenes; Peptide Hydrolases; Recombinant Proteins; Sulfonamides; Triterpenes; Tumor Necrosis Factor-alpha | 2012 |